Fig. 1From: Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1–August 20, 2021): a retrospective observational monocentric studyFDA Emergency Use Authorization (EUA) criteria of casirivimab/imdevimabBack to article page